The single most effective way to prevent Ramsay Hunt syndrome is getting vaccinated against shingles, since the condition is caused by the same virus. Ramsay Hunt syndrome occurs when the chickenpox virus, which stays dormant in your nerve cells after infection, reactivates in the facial nerve near your ear. This reactivation causes facial paralysis, severe ear pain, and often a blistering rash on or around the ear. While you can’t eliminate every risk factor, vaccination dramatically reduces your chances, and knowing the early warning signs can protect you from the worst outcomes if it does occur.
Why Ramsay Hunt Syndrome Happens
If you had chickenpox as a child, the varicella-zoster virus never fully left your body. It retreated into clusters of nerve cells called ganglia, where it can sit quietly for decades. When conditions are right, typically when your immune system weakens, the virus can reactivate. If it reactivates in the geniculate ganglion, a nerve hub near your ear that controls facial movement, the result is Ramsay Hunt syndrome.
The reactivation is essentially the same process that causes shingles elsewhere on the body. The difference is location. When the virus travels along the facial nerve, it can damage the nerve fibers that control the muscles on one side of your face, cause intense ear pain, and produce fluid-filled blisters in or around the ear canal. Some people also experience hearing loss, ringing in the ear, or dizziness.
Get the Shingles Vaccine
The recombinant shingles vaccine (Shingrix) is the most powerful prevention tool available. It provides roughly 97% protection against shingles in adults 50 and older, and about 90% protection in those 70 and older. Because Ramsay Hunt syndrome is a form of shingles, preventing shingles means preventing Ramsay Hunt.
The CDC recommends two doses of Shingrix, spaced two to six months apart, for all adults 50 and older. You should get it even if you’ve already had shingles, already received the older live vaccine (Zostavax), or don’t remember having chickenpox. Most adults who grew up before the chickenpox vaccine was available carry the dormant virus whether they recall the illness or not.
For people under 50 who are immunocompromised, the vaccine is recommended starting at age 19. This includes people living with HIV, those with blood cancers, people on immunosuppressive medications for autoimmune conditions, and organ transplant recipients. In these groups, vaccine efficacy is lower but still meaningful, ranging from about 68% to 91% depending on the specific condition. The risk of shingles in younger immunocompromised adults can be as high as or higher than in the general population over 50, which is why earlier vaccination matters.
If you know you’ll be starting immunosuppressive therapy, such as chemotherapy or medications for an autoimmune disease, the ideal time to get vaccinated is before treatment begins. If that window has passed, vaccination during a period of lower immunosuppression and stable disease gives you the best immune response. Shingrix is not a live vaccine, so it’s safe to receive even while taking antiviral medications or during immunosuppressive treatment.
Reduce Your Reactivation Triggers
The virus reactivates when your immune system’s surveillance weakens. Several factors are clinically linked to this: chronic psychological stress, diabetes, chronic lung disease, fever, and physical exhaustion. You can’t control all of these, but managing the ones you can makes a difference.
Chronic stress is one of the most well-documented triggers. Sustained psychological stress suppresses the immune cells that keep dormant viruses in check. This connection was reinforced during the COVID-19 pandemic, when researchers observed increased shingles rates among patients experiencing both the physiological and psychological stress of infection. Prioritizing sleep, managing chronic stressors, and staying physically active all support the immune function that keeps the virus dormant.
If you have diabetes or another chronic condition, keeping it well controlled reduces your baseline risk. Poorly managed blood sugar, for example, impairs immune function over time and creates an environment where viral reactivation is more likely.
Recognize the Early Warning Signs
Prevention isn’t only about stopping the virus from reactivating. It’s also about catching it early enough to prevent permanent damage. When treatment begins promptly, the facial paralysis recovery rate is as high as 75%. Treatment started within the first week of symptoms still helps, but earlier is better.
The earliest symptom in most cases is severe pain on one side of the ear. This shows up first in about 55% of patients, typically one to three days before facial weakness or any rash appears. The pain is often described as sharp or stabbing and can be intense enough to wake you from sleep. A vague prodrome of headache, fatigue, and low-grade fever sometimes precedes even the ear pain by a day or two.
Facial paralysis is the first noticeable symptom in about 23% of cases. The rash, when it appears, starts as small red bumps that progress to blisters, then crust over within one to seven days. In up to 30% of cases, no rash appears at all, which makes the condition harder to distinguish from Bell’s palsy. The key differentiator is the severity of ear pain: Ramsay Hunt typically causes much more intense pain than Bell’s palsy.
If you develop sudden, severe ear pain on one side, especially with any facial weakness or blistering near the ear, treat it as urgent. The window for starting antiviral therapy is narrow, and the speed of treatment directly affects your odds of full recovery.
Who Faces the Highest Risk
Your risk rises with age, primarily because immune function naturally declines over time. Adults over 60 face the highest rates of shingles reactivation in the general population. But age isn’t the only factor. People taking medications that suppress the immune system, such as those used for rheumatoid arthritis, lupus, or inflammatory bowel disease, face elevated risk regardless of age. So do people undergoing cancer treatment, organ transplant recipients on anti-rejection drugs, and those living with HIV.
Even significant life events that temporarily weaken immunity, like a major surgery, prolonged illness, or an extended period of severe stress, can create a window for reactivation. If you fall into any of these categories and haven’t been vaccinated, the benefit of Shingrix is substantial. For immunocompromised adults 19 and older, vaccination is now specifically recommended by the CDC, with an option to shorten the interval between doses to one to two months when faster protection is needed.